- Home
- KNTK vs RARE Comparison
KNTK vs RARE Comparison
Compare KNTK & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNTK
- RARE
- Stock Information
- Founded
- KNTK 2017
- RARE 2010
- Country
- KNTK United States
- RARE United States
- Employees
- KNTK N/A
- RARE N/A
- Industry
- KNTK Natural Gas Distribution
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- KNTK Utilities
- RARE Health Care
- Exchange
- KNTK Nasdaq
- RARE Nasdaq
- Market Cap
- KNTK 2.6B
- RARE 2.6B
- IPO Year
- KNTK N/A
- RARE 2014
- Fundamental
- Price
- KNTK $40.80
- RARE $29.69
- Analyst Decision
- KNTK Buy
- RARE Strong Buy
- Analyst Count
- KNTK 9
- RARE 14
- Target Price
- KNTK $55.33
- RARE $86.64
- AVG Volume (30 Days)
- KNTK 1.0M
- RARE 2.1M
- Earning Date
- KNTK 08-06-2025
- RARE 08-05-2025
- Dividend Yield
- KNTK 7.64%
- RARE N/A
- EPS Growth
- KNTK N/A
- RARE N/A
- EPS
- KNTK 0.73
- RARE N/A
- Revenue
- KNTK $1,652,079,000.00
- RARE $610,159,000.00
- Revenue This Year
- KNTK $28.60
- RARE $18.70
- Revenue Next Year
- KNTK $19.45
- RARE $26.76
- P/E Ratio
- KNTK $55.66
- RARE N/A
- Revenue Growth
- KNTK 19.71
- RARE 26.77
- 52 Week Low
- KNTK $39.33
- RARE $25.81
- 52 Week High
- KNTK $67.60
- RARE $60.37
- Technical
- Relative Strength Index (RSI)
- KNTK 42.91
- RARE 51.57
- Support Level
- KNTK $40.52
- RARE $27.00
- Resistance Level
- KNTK $43.95
- RARE $29.37
- Average True Range (ATR)
- KNTK 1.33
- RARE 1.12
- MACD
- KNTK -0.10
- RARE 0.52
- Stochastic Oscillator
- KNTK 8.16
- RARE 88.55
About KNTK Kinetik Holdings Inc.
Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.